Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 29, 2021 at 01:54 pm EDT
Share
Sinphar Pharmaceutical Co.,Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 2,388.452 million compared to TWD 2,394.589 million a year ago. Operating loss was TWD 122.197 million compared to TWD 146.970 million a year ago. Net loss was TWD 28.510 million compared to net income of TWD 13.961 million a year ago. Basic loss per share from continuing operations was TWD 0.17 compared to basic earnings per share from continuing operations of TWD 0.08 a year ago.
Sinphar Pharmaceutical Co., Ltd. is principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company is also engaged in the sales of functional food products. The Companyâs principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The Company mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
SINPHAR PHARMACEUTICAL CO.,LTD. 